NYSE:MET - Metlife Stock Price, News, & Analysis

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife announced a quarterly dividend on Friday, July 6th. Shareholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a yield of 3.65%. The ex-dividend date is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its Board of Directors has initiated a share repurchase plan on Tuesday, May 22nd 2018, which permits the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 3.1% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

Metlife Inc (NYSE:MET) announced its earnings results on Wednesday, August, 1st. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.17 by $0.13. The financial services provider had revenue of $21.22 billion for the quarter, compared to analysts' expectations of $15.65 billion. Metlife had a net margin of 6.12% and a return on equity of 9.17%. The business's revenue was up 36.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.04 EPS. View Metlife's Earnings History.

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Metlife.

15 brokers have issued 1 year target prices for Metlife's stock. Their forecasts range from $48.00 to $63.00. On average, they anticipate Metlife's stock price to reach $55.00 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price. View Analyst Price Targets for Metlife.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 8 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

Metlife saw a increase in short interest during the month of July. As of July 13th, there was short interest totalling 14,206,280 shares, an increase of 18.2% from the June 29th total of 12,020,301 shares. Based on an average daily trading volume, of 4,474,570 shares, the short-interest ratio is presently 3.2 days. Approximately 1.6% of the shares of the stock are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Athene (ATH).

Media coverage about MET stock has trended somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Metlife earned a media and rumor sentiment score of 0.07 on Accern's scale. They also gave news stories about the financial services provider an impact score of 45.74 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for Metlife.

Metlife's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.11%), FMR LLC (4.60%), Massachusetts Financial Services Co. MA (2.41%), Bank of New York Mellon Corp (1.28%), Diamond Hill Capital Management Inc. (1.04%) and Epoch Investment Partners Inc. (0.87%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Epoch Investment Partners Inc., BlackRock Inc., Canada Pension Plan Investment Board, Bank of Montreal Can, Jennison Associates LLC, Caisse DE Depot ET Placement DU Quebec and United Services Automobile Association. View Insider Buying and Selling for Metlife.

MET stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Pzena Investment Management LLC, Morgan Stanley, Robeco Institutional Asset Management B.V., Putnam Investments LLC, Sumitomo Mitsui Trust Holdings Inc., LSV Asset Management and First Trust Advisors LP. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $46.04.

Metlife has a market capitalization of $44.42 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.